Autonomix Medical, Inc. (NASDAQ:AMIX) Short Interest Up 198.9% in December

Autonomix Medical, Inc. (NASDAQ:AMIX) was the recipient of a significant growth in short interest in December. As of December 15th, there was short interest totalling 109,400 shares, a growth of 198.9% from the November 30th total of 36,600 shares. Approximately 9.2% of the shares of the stock are sold short. Based on an average daily trading volume, of 534,900 shares, the short-interest ratio is presently 0.2 days.

Analysts Set New Price Targets

Separately, LADENBURG THALM/SH SH initiated coverage on Autonomix Medical in a report on Tuesday, September 3rd. They set a “buy” rating and a $28.00 target price for the company.

Autonomix Medical Trading Down 5.4 %

Shares of AMIX stock traded down $0.19 during trading hours on Friday, reaching $3.30. 41,308 shares of the stock traded hands, compared to its average volume of 218,191. The company has a quick ratio of 4.26, a current ratio of 4.26 and a debt-to-equity ratio of 0.36. The firm has a market capitalization of $3.80 million and a PE ratio of -0.21. Autonomix Medical has a 1-year low of $2.88 and a 1-year high of $152.00. The business has a fifty day moving average price of $7.67 and a 200 day moving average price of $13.46.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.